Ground-breaking approach accelerates drug discovery process
An international collaboration between Imperial College London, Singapore's Duke-NUS Medical School and Belgium-based pharmaceutical company UCB led to the discovery of a new anti-epileptic drug target and a whole new approach ...
Sep 3, 2018
0
170